Portfolio Lab

BeOne Medicines Ltd.

  • Stock
  • Ticker ONC
  • ISIN US07725L1026
  • Nasdaq
  • US listing in dollars (ADR)

Health care · Pharmaceuticals · USA

$390.94 −2.19%
Close of 20 Nov 2026
Open in backtest

Performance, volatility and drawdowns of BeOne Medicines Ltd. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.

Performance

ONCGlobal equities (VT)

$10,000 grew to $124,069. Global equities (VT): $29,042.

Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.

Declines from the peak

Lowest point −70.0% in 05/2022, measured from the peak in 09/2021. It took 62 months to get back to the old peak.

1-year return
+11.9%
5-year return p.a.
+1.4%
10-year return p.a.
+28.6%
Volatility p.a.
52.2%
Largest decline
−70.0%

Financial statements

Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures

Quarter end12/202403/202506/202509/202512/202503/202606/202609/2026
Income statement
Revenue1,1281,1171,3151,4121,4981,5131,7051,890
Gross profit9679521,1511,2161,3561,3461,5311,673
Operating income-791188163185250325419
EBITDA-2944118199221291364456
Net income-1521.39412567227237385
Earnings per share-1.420.010.841.090.571.962.053.28
Balance sheet
Total assets5,9215,8426,2987,6338,1898,5549,1769,876
Liabilities2,5892,3422,5283,5033,8273,7934,0024,056
Equity3,3323,5003,7704,1294,3614,7605,1745,820
Cash2,6272,5162,7564,0374,5484,7925,0985,781
Long-term debt166160146–962963882825
Cash flow
Operating cash flow7544264403417201463509
Capital expenditure-92-56-44-48-38-41-27-35
Free cash flow-17-12220354380161435474

Value it:DCF calculatorMultiples calculator

Annual returns

Best year 2017 at +221.9%, weakest 2022 at −18.8%. 7 of 9 full years were positive. * partial year.

Quarterly reports

Filing date with the SEC and earnings per share of the quarter

DayEarnings per share
5 Nov 2026$3.28
5 Aug 2026$2.05
6 May 2026$1.96
26 Feb 2026$0.57
6 Nov 2025$1.09
6 Aug 2025$0.84
7 May 2025$0.01
27 Feb 2025−$1.42
12 Nov 2024−$1.15
7 Aug 2024−$1.15
8 May 2024−$2.41
26 Feb 2024−$3.53

Key metrics

Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.

Valuation

Market cap
€40bn
Market cap in trading currency
$44.7bn
Enterprise value
$39.7bn
P/E
49.7
P/S
6.76
P/B
7.67
EV/Sales
6.02
EV/EBITDA
29.8
Earnings yield
2.0%
FCF yield
3.2%

Results (last four quarters)

Revenue
$6.61bn
Gross profit
$5.91bn
EBITDA
$1.33bn
Net income
$916m
Earnings per share
$7.86
Revenue per share
$57.84
Revenue growth
+33.8%
Earnings growth
+208.2%

Profitability

Gross margin
89.4%
Operating margin
17.8%
Net margin
13.9%
Return on equity
18.4%
Return on assets
9.3%

Balance sheet and cash flow

Cash
$5.78bn
Cash per share
$50.61
Financial debt
$866m
Debt/equity %
15
Current ratio
3.55
Book value per share
$50.96
Operating cash flow
$1.59bn
Free cash flow
$1.45bn

Dividend

Dividend yield
0.00%
Dividend (12 months)
$0.00
Yield (12 months)
0.00%
Payout ratio
0%
Ex-dividend date
–

Shares and trading

Shares outstanding
114m
Volume
356,774
Avg. volume 3 months
404,016
Relative volume
0.9

Price and technicals

Price
$390.94
1 day
−2.2%
52-week high
$424.00
52-week low
$260.27
Distance to 52-week high
−7.8%
Distance to 52-week low
+50.2%
Distance to 50-day line
+4.4%
Distance to 200-day line
+18.7%
RSI (14)
50
Volatility 1M
37.8%

Performance

1 week
−6.1%
1 month
+2.3%
3 months
+5.1%
6 months
+26.0%
YTD
+28.7%
1 year
+10.5%

Dates

Fiscal year end
31 Dec 2025
Most recent quarter
30 Sep 2026

Frequently asked questions

How has ONC performed since 11/2016?

$10,000 grew to $124,069 by 20 Nov 2026, which is +28.7% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.

How volatile is ONC?

Volatility was 52.2% per year, measured on monthly returns. The largest decline from a peak was −70.0%, with the low in 05/2022.

How does ONC compare with a broad equity ETF?

Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ONC returned +28.7% at 52.2%. The correlation of monthly returns was 0.25; 1 would mean they moved in lockstep.

Which currency are the figures in?

In US dollars, the currency of the US listing.

Why does this page show a US listing?

The figures use the stock's depositary receipt (ADR) traded in the US. On individual days its path differs slightly from the price on the home exchange.

Not investment advice. Metrics and financial statements calculated from the company's mandatory filings with the SEC, without guarantee; amounts in US dollars.

Reference data of securities: source ESMA (FIRDS reference data) and SEC (EDGAR).

Not investment advice: results in Portfolio Lab are model calculations based on historical data and your inputs. Past performance is not a reliable indicator of future results.

BeOne Medicines Ltd. (ONC): Return and risk | Portfolio Lab